Supernus Pharmaceuticals, Inc. (LON:0LB2)
London flag London · Delayed Price · Currency is GBP · Price in USD
33.25
+0.84 (2.59%)
At close: Jul 10, 2025

Supernus Pharmaceuticals Revenue

Supernus Pharmaceuticals had revenue of $149.82M USD in the quarter ending March 31, 2025, with 4.30% growth. This brings the company's revenue in the last twelve months to $668.00M, up 11.82% year-over-year. In the year 2024, Supernus Pharmaceuticals had annual revenue of $661.82M with 8.94% growth.

Revenue (ttm)
$668.00M
Revenue Growth
+11.82%
P/S Ratio
2.96
Revenue / Employee
$991.09K
Employees
674
Market Cap
1.53B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 661.82M 54.30M 8.94%
Dec 31, 2023 607.52M -59.72M -8.95%
Dec 31, 2022 667.24M 87.46M 15.09%
Dec 31, 2021 579.78M 59.38M 11.41%
Dec 31, 2020 520.40M 127.64M 32.50%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
GSK plc 31.53B
Haleon 11.23B
Smith & Nephew 4.64B
ConvaTec Group 1.83B
Hikma Pharmaceuticals 2.50B
HUTCHMED (China) 503.39M
Oxford Nanopore Technologies 183.19M
Revenue Rankings